Ribosomal Protein S6 Activators
Common Ribosomal Protein S6 Activators include, but are not limited to Insulin CAS 11061-68-0, L-Leucine CAS 61-90-5, PMA CAS 16561-29-8, Dexamethasone CAS 50-02-2 and Rapamycin CAS 53123-88-9.
Ribosomal Protein S6 (RPS6) activators constitute a chemical class of compounds that are involved in regulating the activity of RPS6, a crucial component of the ribosome. Ribosomes are cellular organelles responsible for protein synthesis, and RPS6 is one of its structural components. RPS6 plays a pivotal role in the translation process, where genetic information stored in messenger RNA (mRNA) is translated into functional proteins. Activators in this class are thought to modulate the phosphorylation or activation state of RPS6, which, in turn, influences the efficiency of protein synthesis within the cell.
The activation of RPS6 is often associated with cell growth and proliferation. When cells receive signals, such as those from growth factors or nutrients, various signaling pathways are activated, leading to the phosphorylation of RPS6. This phosphorylation event results in an increase in ribosomal protein synthesis, facilitating cell growth and division. RPS6 activators are believed to enhance this phosphorylation process, thereby promoting cellular growth and protein production. These compounds can impact various cellular processes, including cell differentiation, tissue regeneration, and immune responses. Understanding the mechanisms by which RPS6 activators function is vital for uncovering their roles in physiological and pathological contexts, contributing to a broader comprehension of cellular processes and revealing novel avenues for research and drug development.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K/Akt/mTOR pathway, which can lead to rpS6 phosphorylation. | ||||||
L-Leucine | 61-90-5 | sc-364173 sc-364173A | 25 g 100 g | $21.00 $62.00 | ||
Amino acids, especially leucine, can activate mTORC1, which can result in rpS6 phosphorylation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA can activate the mTOR pathway in certain contexts, influencing rpS6 phosphorylation. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoids like dexamethasone can modulate mTOR signaling, potentially influencing rpS6 expression or phosphorylation. | ||||||
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
LPS can activate mTOR signaling in immune cells, potentially affecting rpS6 phosphorylation. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
This ER stress inducer can modulate mTOR signaling, potentially influencing rpS6 status. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
This MDM2 antagonist has been reported to influence rpS6 phosphorylation in certain contexts. | ||||||
D-Sorbitol | 50-70-4 | sc-203278A sc-203278 | 100 g 1 kg | $29.00 $69.00 | ||
Sorbitol-induced osmotic stress has been shown to activate the mTOR (mechanistic target of rapamycin) pathway in certain contexts. The mTOR pathway, when activated, leads to the phosphorylation of several downstream targets, including rpS6. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
This protein synthesis inhibitor can modulate mTOR pathway activity, potentially influencing rpS6 phosphorylation. | ||||||